The company utilizes a variety of raw materials and components, including chemicals and electronic parts, for its Diagnostics product line. Supply disruptions caused by pandemics, epidemics, labor strikes, geopolitical conflicts such as the Russia-Ukraine war and Middle East hostilities, civil unrest, terrorism, or transportation challenges could adversely affect production, operating costs, profit margins, and testing capacity. Shortages or unavailability of critical components, such as enzymes, may lead to backorders and necessitate product modifications. The company operates laboratory facilities in Chicago, Illinois; Atlanta, Georgia; Raleigh, North Carolina; Aliso Viejo, California; and Minneapolis, Minnesota, which do not have fully redundant capabilities. Damage or inoperability of these facilities due to disasters or other events could disrupt testing operations, damage the company's reputation, and result in customer loss. Rebuilding or replacing these facilities involves significant costs and time, is complicated by licensure and accreditation requirements, and third-party testing agreements may not be commercially viable.
Tempus Ai Inc's Comment on Supply Chain
The company utilizes a variety of raw materials and components, including chemicals and electronic parts, for its Diagnostics product line. Supply disruptions caused by pandemics, epidemics, labor strikes, geopolitical conflicts such as the Russia-Ukraine war and Middle East hostilities, civil unrest, terrorism, or transportation challenges could adversely affect production, operating costs, profit margins, and testing capacity. Shortages or unavailability of critical components, such as enzymes, may lead to backorders and necessitate product modifications. The company operates laboratory facilities in Chicago, Illinois; Atlanta, Georgia; Raleigh, North Carolina; Aliso Viejo, California; and Minneapolis, Minnesota, which do not have fully redundant capabilities. Damage or inoperability of these facilities due to disasters or other events could disrupt testing operations, damage the company's reputation, and result in customer loss. Rebuilding or replacing these facilities involves significant costs and time, is complicated by licensure and accreditation requirements, and third-party testing agreements may not be commercially viable.
Sources:
Tempus Ai Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Tempus Ai Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
